{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:54:34Z","timestamp":1793296474047,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004897","name":"European Organisation for Research and Treatment of Cancer","doi-asserted-by":"publisher","award":["015\/2016"],"award-info":[{"award-number":["015\/2016"]}],"id":[{"id":"10.13039\/501100004897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.eclinm.2025.103153","type":"journal-article","created":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T23:01:01Z","timestamp":1742598061000},"page":"103153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Prognostic value of baseline EORTC QLQ-C30 scores for overall survival across 46 clinical trials covering 17 cancer types: a validation study"],"prefix":"10.1016","volume":"82","author":[{"given":"Luigi","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigirl","family":"Machingura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mekdes","family":"Taye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline","family":"Pe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corneel","family":"Coens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahu","family":"Alanya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Antunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan","family":"Basch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolie","family":"Ringash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Brandberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mogens","family":"Groenvold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Eggermont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Van Meerbeeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Koller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winette T.A.","family":"Van der Graaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J.B.","family":"Taphoorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3648-9616","authenticated-orcid":false,"given":"Johan A.F.","family":"Koekkoek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap C.","family":"Reijneveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Soffietti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina","family":"Velikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Bottomley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6978-1587","authenticated-orcid":false,"given":"Henning","family":"Flechtner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jammbe","family":"Musoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2025.103153_bib1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/1758834010395342","article-title":"Health-related quality of life and cancer clinical trials","volume":"3","author":"Osoba","year":"2011","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.eclinm.2025.103153_bib2","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.ejca.2005.05.007","article-title":"Health related quality of life outcomes in cancer clinical trials","volume":"41","author":"Bottomley","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.eclinm.2025.103153_bib3","doi-asserted-by":"crossref","first-page":"e267","DOI":"10.1016\/S1470-2045(18)30097-4","article-title":"Incorporating the patient experience into regulatory decision making in the USA, Europe, and Canada","volume":"19","author":"Kluetz","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eclinm.2025.103153_bib4","series-title":"Guidance for industry. Patient-reported outcome measures: use in medical product development to support labelling claims","year":"2009"},{"key":"10.1016\/j.eclinm.2025.103153_bib5","series-title":"The evaluation of medicinal products, doc. Ref.\u00a0EMEA\/CHMP\/EWP\/139391\/2004","article-title":"Reflection paper on the regulatory guidance for the use of health-related quality of life (HRQL) measures","year":"2005"},{"key":"10.1016\/j.eclinm.2025.103153_bib6","series-title":"The use of patient-reported outcome (PRO) measures in oncology studies","article-title":"Appendix 2 to the guideline on the evaluation of anticancer medicinal products in man","year":"2016"},{"key":"10.1016\/j.eclinm.2025.103153_bib7","first-page":"17","article-title":"Endpoints in cancer clinical trials","volume":"151","author":"Fiteni","year":"2014","journal-title":"J\u00a0Visc Surg"},{"key":"10.1016\/j.eclinm.2025.103153_bib8","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ejca.2015.10.004","article-title":"Prognostic value of health-related quality of life for overall survival in elderly non-small-cell lung cancer patients","volume":"52","author":"Fiteni","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.eclinm.2025.103153_bib9","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1093\/annonc\/mdl183","article-title":"Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975","volume":"17","author":"Efficace","year":"2006","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.eclinm.2025.103153_bib10","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.cllc.2023.03.007","article-title":"Association between quality of life questionnaire at diagnosis and survival in patients with lung cancer","volume":"24","author":"Hong","year":"2023","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.eclinm.2025.103153_bib11","doi-asserted-by":"crossref","first-page":"432","DOI":"10.21037\/tlcr-21-938","article-title":"The predictive utility of patient-reported outcomes and performance status for survival in metastatic lung cancer patients treated with chemoimmunotherapy","volume":"11","author":"Badaoui","year":"2022","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.eclinm.2025.103153_bib12","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.ejca.2004.01.014","article-title":"Baseline health-related quality-of-life data as prognostic factors in a phase III multicentre study of women with metastatic breast cancer","volume":"40","author":"Efficace","year":"2004","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.eclinm.2025.103153_bib13","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12955-016-0449-z","article-title":"Patient-reported pain and other quality of life domains as prognostic factors for survival in a phase III clinical trial of patients with advanced breast cancer","volume":"14","author":"Smyth","year":"2016","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.eclinm.2025.103153_bib14","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/sj.bjc.6605649","article-title":"Self-reported health-related quality of life is an independent predictor of chemotherapy treatment benefit and toxicity in women with advanced breast cancer","volume":"102","author":"Lee","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.eclinm.2025.103153_bib15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10549-006-9447-x","article-title":"Psychological distress and fatigue predicted recurrence and survival in primary breast cancer patients","volume":"105","author":"Groenvold","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.eclinm.2025.103153_bib16","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/onco.13806","article-title":"Patient-reported outcomes predict progression-free survival of patients with advanced breast cancer treated with abemaciclib","volume":"26","author":"Badaoui","year":"2021","journal-title":"Oncologist"},{"key":"10.1016\/j.eclinm.2025.103153_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100475","article-title":"Patient-reported outcomes predict survival and adverse events following anticancer treatment initiation in advanced HER2-positive breast cancer","volume":"7","author":"Modi","year":"2022","journal-title":"ESMO Open"},{"key":"10.1016\/j.eclinm.2025.103153_bib18","doi-asserted-by":"crossref","first-page":"5731","DOI":"10.1200\/JCO.2007.11.1476","article-title":"Prognostic value of health-related quality-of-life data in predicting survival in patients with anaplastic oligodendrogliomas, from a phase III EORTC brain cancer group study","volume":"25","author":"Mauer","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.eclinm.2025.103153_bib19","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/sj.bjc.6603876","article-title":"The prognostic value of health-related quality-of-life data in predicting survival in glioblastoma cancer patients: results from an international randomised phase III EORTC Brain Tumour and Radiation Oncology Groups, and NCIC Clinical Trials Group study","volume":"97","author":"Mauer","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.eclinm.2025.103153_bib20","first-page":"1","article-title":"Prognostic values of EORTC QLQ-C30 and QLQ-HCC18 index-scores in patients with hepatocellular carcinoma - clinical application of health-related quality-of-life data","volume":"17","author":"Li","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.eclinm.2025.103153_bib21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3233\/BLC-211613","article-title":"Association between patient-reported outcomes and survival in patients with advanced urothelial carcinoma treated with atezolizumab","volume":"8","author":"Tan","year":"2022","journal-title":"Bladder Cancer"},{"key":"10.1016\/j.eclinm.2025.103153_bib22","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1200\/JCO.2007.13.3439","article-title":"The prognostic significance of patient-reported outcomes in cancer clinical trials","volume":"26","author":"Gotay","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.eclinm.2025.103153_bib23","doi-asserted-by":"crossref","first-page":"e685","DOI":"10.1016\/S1470-2045(19)30656-4","article-title":"Prognostic value of patient-reported outcomes from international randomised clinical trials on cancer: a systematic review","volume":"20","author":"Mierzynska","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eclinm.2025.103153_bib24","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1586\/14737167.8.2.179","article-title":"Prognostic factor analysis of health-related quality of life data in cancer: a statistical methodological evaluation","volume":"8","author":"Mauer","year":"2008","journal-title":"Expert Rev Pharmacoeconomics Outcomes Res"},{"key":"10.1016\/j.eclinm.2025.103153_bib25","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S1470-2045(09)70200-1","article-title":"Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials","volume":"10","author":"Quinten","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eclinm.2025.103153_bib26","first-page":"27","article-title":"External validation of clinical prediction models using big datasets from e-health records or IPD meta-analysis: opportunities and challenges","volume":"353","author":"Riley","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.eclinm.2025.103153_bib27","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1002\/cncr.31556","article-title":"Quality of life as a prognostic indicator of survival: a pooled analysis of individual patient data from canadian cancer trials group clinical trials","volume":"124","author":"Ediebah","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.eclinm.2025.103153_bib28","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organisation for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.eclinm.2025.103153_bib29","series-title":"The EORTC QLQ-C30 scoring manual","author":"Fayers","year":"2001"},{"key":"10.1016\/j.eclinm.2025.103153_bib30","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jval.2020.11.004","article-title":"Past and current practice of patient-reported outcome measurement in randomized cancer clinical trials: a systematic review","volume":"24","author":"Giesinger","year":"2021","journal-title":"Value Heal J Int Soc Pharmacoeconomics Outcomes Res"},{"key":"10.1016\/j.eclinm.2025.103153_bib31","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"Cox","year":"1972","journal-title":"J\u00a0R Stat Soc Ser B"},{"key":"10.1016\/j.eclinm.2025.103153_bib32","series-title":"Modeling survival data: extending the Cox model","first-page":"39","article-title":"The Cox model","author":"Therneau","year":"2000"},{"key":"10.1016\/j.eclinm.2025.103153_bib33","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1200\/JCO.1998.16.1.139","article-title":"Interpreting the significance of changes in health-related quality-of-life scores","volume":"16","author":"Osoba","year":"1998","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.eclinm.2025.103153_bib34","first-page":"555","article-title":"The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30","volume":"5","author":"King","year":"1996","journal-title":"Qual life Res an Int J Qual life Asp Treat care Rehabil"},{"key":"10.1016\/j.eclinm.2025.103153_bib35","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejca.2023.04.027","article-title":"Minimally important differences for interpreting EORTC QLQ-C30 change scores over time: a synthesis across 21 clinical trials involving nine different cancer types","volume":"188","author":"Musoro","year":"2023","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.eclinm.2025.103153_bib36","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","article-title":"Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors","volume":"15","author":"Harrell","year":"1996","journal-title":"Stat Med"},{"key":"10.1016\/j.eclinm.2025.103153_bib37","series-title":"Base SAS9.4 procedures guide","year":"2013"},{"key":"10.1016\/j.eclinm.2025.103153_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jclinepi.2019.10.003","article-title":"Thresholds for clinical importance were established to improve interpretation of the EORTC QLQ-C30 in clinical practice and research","volume":"118","author":"Giesinger","year":"2020","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.eclinm.2025.103153_bib39","doi-asserted-by":"crossref","first-page":"201","DOI":"10.7326\/0003-4819-144-3-200602070-00009","article-title":"Translating clinical research into clinical practice: impact of using prediction rules to make decisions","volume":"144","author":"Reilly","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eclinm.2025.103153_bib40","doi-asserted-by":"crossref","first-page":"6026","DOI":"10.1038\/s41467-022-33826-4","article-title":"Key considerations to reduce or address respondent burden in patient-reported outcome (PRO) data collection","volume":"13","author":"Aiyegbusi","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.eclinm.2025.103153_bib41","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/cncr.28382","article-title":"A\u00a0global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites","volume":"120","author":"Quinten","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.eclinm.2025.103153_bib42","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1056\/NEJMra1712502","article-title":"Cancer survivorship","volume":"379","author":"Shapiro","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.eclinm.2025.103153_bib43","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/cncr.33348","article-title":"Health-related quality of life outcomes among breast cancer survivors","volume":"127","author":"Park","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.eclinm.2025.103153_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2022.03.039","article-title":"Clustering of EORTC QLQ-C30 health-related quality of life scales across several cancer types: validation study","volume":"170","author":"Machingura","year":"2022","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.eclinm.2025.103153_bib45","series-title":"Multicollinearity in prognostic factor analyses using the EORTC QLQ-C30 : identi\u00ffcation and impact on model","first-page":"3865","volume":"vol. 3884","author":"Steen","year":"2002"},{"key":"10.1016\/j.eclinm.2025.103153_bib46","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jclinepi.2015.08.007","article-title":"Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robust","volume":"69","author":"Giesinger","year":"2016","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.eclinm.2025.103153_bib47","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jval.2020.10.017","article-title":"Patient-reported outcomes as independent prognostic factors for survival in oncology: systematic review and meta-analysis","volume":"24","author":"Efficace","year":"2021","journal-title":"Value Heal"},{"key":"10.1016\/j.eclinm.2025.103153_bib48","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/jnci\/djad152","article-title":"Time to deterioration of patient-reported outcomes as a surrogate of overall survival: a meta-analysis","volume":"115","author":"Shahnam","year":"2023","journal-title":"J\u00a0Natl Cancer Inst"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537025000859?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537025000859?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T20:42:27Z","timestamp":1786135347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537025000859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":48,"alternative-id":["S2589537025000859"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2025.103153","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic value of baseline EORTC QLQ-C30 scores for overall survival across 46 clinical trials covering 17 cancer types: a validation study","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2025.103153","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103153"}}